Annual report pursuant to Section 13 and 15(d)

Assets and Liabilities Held for Sale

Assets and Liabilities Held for Sale
12 Months Ended
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Assets and Liabilities Held for Sale
3. Assets and Liabilities Held for Sale

In November 2022, the Company reached an agreement to sell the Biodex Rehabilitation ("Rehab") business to Salona Global for a purchase price of $8.0 million. The sale is subject to customary regulatory approvals and procedures, and is expected to close in the second quarter of 2023. As of December 31, 2022, the Company classified the assets and liabilities of Rehab as held for sale, and recorded an impairment loss of $3.5 million during the period ended December 31, 2022 representing the difference between fair value less cost to sell and carrying value. The following table presents information related to the major classes of assets and liabilities that were classified as held for sale:

December 31, 2022
Inventories $ 3.9 
Prepaid expenses and other current assets 0.1 
Property, plant and equipment — net 0.7 
Goodwill 3.8 
Assets held for sale $ 8.5 
Accrued liabilities 0.7 
Other non-current liabilities 0.1 
Liabilities held for sale (1)
$ 0.8 
(1)Included in accrued expenses and other liabilities within the consolidated balance sheets.